Literature DB >> 18076054

Xenobiotic activity in serum and sperm chromatin integrity in European and inuit populations.

Tanja Krüger1, Marcello Spanò, Manhai Long, Patrizia Eleuteri, Michele Rescia, Philip S Hjelmborg, Gian-Carlo Manicardi, Davide Bizzaro, Alexander Giwercman, Gunnar Toft, Jens Peter Bonde, Eva C Bonefeld-Jorgensen.   

Abstract

Lipophilic persistent organic pollutants (POPs) are ubiquitous in the environment and suspected to interfere with hormone activities and reproduction. In previous studies we demonstrated that POP exposure can affect sperm DNA integrity and differences between Inuits and Europeans in sperm DNA integrity and xenobiotic activity were observed. The aim of this study was to investigate possible relations between human sperm chromatin integrity and the xenobiotic serum activity of lipophilic POPs assessed as effects on the estrogen (ER), androgen (AR), and/or aryl hydrocarbon (AhR) receptors. Human sperm chromatin integrity was assessed as DNA fragmentation index (%DFI) and high DNA stainability (%HDS) using the flow cytometric sperm chromatin structure assay (SCSA). Xenobiotic receptor activities were determined using chemically activated luciferase gene expression (CALUX) assay. The study included 53 Greenlandic Inuits and 247 Europeans (Sweden, Warsaw (Poland) and Kharkiv (Ukraine)). A heterogeneous pattern of correlations was found. For Inuits, ER and AhR activities and %DFI were inversely correlated, whereas a positive correlation between AR activity and %DFI was found for Europeans. In contrast, no correlation between receptor activities and %HDS was observed for Inuits but for Europeans positive and negative correlations were observed between ER and AR activities and %HDS, respectively. We suggest that the different patterns of xenobiotic serum activities, in combination with diet associated factors and/or genetics, might be connected to the observed differences in sperm chromatin integrity between the Inuits and Europeans. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18076054     DOI: 10.1002/mrd.20747

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  6 in total

1.  Aryl hydrocarbon receptor gene transitions (c.-742C>T; c.1661G>A) and idiopathic male infertility: a case-control study with in silico and meta-analysis.

Authors:  Younes Aftabi; Abasalt Hosseinzadeh Colagar; Faramarz Mehrnejad; Ensiyeh Seyedrezazadeh; Emadoddin Moudi
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-15       Impact factor: 4.223

2.  AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens.

Authors:  Noriko Kanaya; Duc M Nguyen; Hannah Lu; Yuan-Zhong Wang; Li-Yu Hsin; Myrto Petreas; David Nelson; Weihong Guo; Peggy Reynolds; Tim Synold; Shiuan Chen
Journal:  Breast Cancer Res Treat       Date:  2015-05-12       Impact factor: 4.872

3.  Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women.

Authors:  Vanessa W Lim; Jun Li; Yinhan Gong; Aizhen Jin; Jian-Min Yuan; Eu Leong Yong; Woon-Puay Koh
Journal:  Endocr Relat Cancer       Date:  2014-02-27       Impact factor: 5.678

4.  Time Trend of Persistent Organic Pollutants and Metals in Greenlandic Inuit during 1994-2015.

Authors:  Manhai Long; Maria Wielsøe; Eva Cecilie Bonefeld-Jørgensen
Journal:  Int J Environ Res Public Health       Date:  2021-03-09       Impact factor: 3.390

5.  Xenohormone transactivities are inversely associated to serum POPs in Inuit.

Authors:  Tanja Krüger; Mandana Ghisari; Philip S Hjelmborg; Bente Deutch; Eva C Bonefeld-Jorgensen
Journal:  Environ Health       Date:  2008-07-15       Impact factor: 5.984

Review 6.  Association between environmental contaminants and health outcomes in indigenous populations of the Circumpolar North.

Authors:  Kavita Singh; Peter Bjerregaard; Hing Man Chan
Journal:  Int J Circumpolar Health       Date:  2014-12-05       Impact factor: 1.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.